ZNF460 Activators
ZNF460 activators comprise a diverse group of chemical compounds that indirectly enhance the functional activity of ZNF460, primarily through modulating various cellular signaling pathways and transcriptional regulation mechanisms. Resveratrol, by activating SIRT1, can enhance ZNF460's DNA-binding affinity through deacetylation processes. Similarly, PD 98059 and LY294002, as MEK and PI3K inhibitors respectively, indirectly augment ZNF460 function by reducing competing ERK and AKT signaling, potentially relieving negative regulation on ZNF460. Histone deacetylase inhibitors like Trichostatin A and Sodium Butyrate boost ZNF460 activity by promoting chromatin relaxation, facilitating ZNF460's access to DNA. Forskolin, through elevating cAMP levels and activating PKA, may indirectly enhance ZNF460's transcriptional activity, possibly by phosphorylating substrates that modify ZNF460. Additionally, SP600125 and SB203580, as inhibitors of JNK and p38 MAPK, might support ZNF460 function by modulating these pathways, which could affect transcription factors or coactivators interacting with ZNF460.
Further influencing ZNF460's activity, Rapamycin, an mTOR inhibitor, can modify downstream pathways, potentially altering the translation of proteins that regulate ZNF460. 5-Azacytidine, by reducing DNA methylation, may enhance ZNF460's transcriptional regulation capabilities. The ROCK inhibitor Y-27632 could also support ZNF460 function by altering the actin cytoskeleton, thereby affecting the cellular context for ZNF460's transcriptional activity. Lastly, Dexamethasone, as a glucocorticoid, can indirectly augment ZNF460 activity. It does so by activating glucocorticoid receptors, which might interact with or alter the function of coactivators and regulators of ZNF460, influencing its transcriptional activity. Collectively, these compounds, through their targeted effects on various signaling pathways and transcriptional regulation mechanisms, enhance the functional activity of ZNF460, underlining the intricate network of cellular processes that govern its regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol enhances the zinc finger transcriptional activity of ZNF460 by promoting DNA binding. This polyphenol activates SIRT1, which can deacetylate transcription factors, potentially enhancing ZNF460's DNA-binding affinity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, an MEK inhibitor, indirectly augments ZNF460 function by mitigating ERK pathway activation. This reduction in ERK signaling can enhance ZNF460's transcriptional activity, as ERK may otherwise negatively regulate it. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly enhances ZNF460 activity. By reducing PI3K/AKT signaling, this compound may alleviate negative feedback on transcription factors regulated by this pathway, indirectly supporting ZNF460. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, enhances ZNF460 by increasing histone acetylation, thereby promoting chromatin relaxation. This relaxation potentially enhances ZNF460's access to DNA and its transcriptional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, another HDAC inhibitor, similarly boosts ZNF460 activity by promoting a more open chromatin structure, potentially facilitating ZNF460's binding to DNA and enhancing its transcriptional regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can indirectly enhance ZNF460 activity by activating PKA. PKA may phosphorylate substrates that interact with or modify ZNF460, enhancing its transcriptional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, might indirectly enhance ZNF460 function by modulating the JNK pathway. Reduced JNK signaling could alleviate inhibition on transcription factors or coactivators that interact with ZNF460. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, could indirectly enhance ZNF460 function by modulating pathways downstream of mTOR. This may include altering the translation of proteins that interact with or regulate ZNF460. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, could indirectly enhance ZNF460 by modulating the p38 pathway, potentially affecting transcription factors or coactivators that interact with or regulate ZNF460's activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, potentially enhances ZNF460 by reducing DNA methylation, thus facilitating ZNF460's access to DNA and its transcriptional regulation. | ||||||